Oncology Analytics
As Chief Technology Officer, David brings more than two decades of leadership experience in building market leading, big data analytics solutions for health plans, providers, and life science organizations.
Prior to joining Oncology Analytics, David held the position of chief technology officer and co-founder of TriNetX, where he developed the product design, technology architecture, and provider adoption model for a global big data and analytics network that optimizes clinical trial design and recruitment while enabling discoveries through the creation of real-world evidence. Before TriNetX, Fusari served as chief technology officer at Ability Network, a healthcare revenue cycle management, and claims processing provider, and Sentillion, where he designed the company’s purpose-built for healthcare identity and access management solution, which was rated Best in KLAS for multiple years. Sentillion was acquired by Microsoft, where Fusari served as an executive and principal architect in the health solutions group.
David is an inventor on 19 patents and holds a Bachelors of Science degree in Computer Information Systems from Bryant University.
This person is not in any offices
Oncology Analytics
Oncology Analytics, Inc. provides health plans with an evidence-based, technologically driven approach to utilization management, which is purpose-built for oncology. Used by physicians to support over 2.5 million health plan members in the US and Puerto Rico, the e-Prior Authorization platform is updated daily to accurately reflect more than 6,000 oncology treatment protocols for anti-cancer treatment across all cancer types and stages, including chemotherapy, radiation therapy, precision medicine, targeted therapy and supportive care